Steatotic liver disease in pediatric obesity and increased risk for youth-onset type 2 diabetes
Putri RR, Casswall T, Danielsson P, et al.
Diabetes Care. Pub online 7 Oct 2024.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Glycaemic control metrics and metabolic dysfunction-associated steatotic liver disease in children and adolescents with type 1 diabetes
Maffeis C, Piona C, Morandi A, et al.
Diabetes Obes Metab. Pub online 30 Sept 2024.
Leggi
Type 2 diabetes in children and adolescents: challenges for treatment and potential solutions
Lee Jia Jia I, Zampetti S, Pozzilli P, Buzzetti R
Diabetes Res Clin Pract. Pub online 4 Oct 2024.
Leggi
Efficacy of vitamin D supplementation on glycaemic control in type 2 diabetes: an updated systematic review and meta-analysis of randomized controlled trials
Chen W, Liu L, Hu F
Diabetes Obes Metab. Pub online 3 Oct 2024.
Leggi
The liver fibrosis-8 index is a predictor for all-cause mortality in cardiovascular disease patients: a cohort study
Yang X, Wang J, Zhang X, et al
Diabetes Obes Metab. 2024 Oct 4
Leggi
Intermittent energy restriction for adolescents with obesity: the fast track to health randomized clinical trial
Lister NB, Baur LA, House ET, et al. JAMA Pediatr. Pub online 1 Oct 2024. Abstract e full text
Leggi
Temporary target versus suspended insulin infusion in patients with type 1 diabetes using the MiniMed 780G advanced closed-loop hybrid system during aerobic exercise: a randomized crossover clinical trial
Gómez AM, Henao DC, Muñoz OM, et al.
Diabetes Technol Ther. Pub. online 30 Sep 2024.
Leggi
Metformin use and risk of delirium in older adults with type 2 diabetes
Sun M, Wang X, Lu Z, et al.
Diabetes Care. Pub. online 3 Oct 2024.
Leggi
Glucose-lowering drugs and liver-related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population-based studies
Khanmohammadi S, Habibzadeh A, Kamrul-Hasan ABM, et al.
Diabet Med. Pub. online 28 Sep 2024.
Leggi
Effectiveness of the MyDiaMate application in reducing diabetes distress in adults with type 1 diabetes: study protocol of the multi-national, randomised-controlled MyREMEDY trial
Mohr TC, de Wit M, Embaye J, et al.
Diabet Med. Pub. online 30 Sep 2024.
Leggi